Intra-patient variability in tacrolimus trough concentrations and renal function decline in pediatric renal transplant recipients

Pediatric Transplantation

Volumn 16, Issue 6, 2012, Pages 613-618

  Prytula, Agnieszka A ^a   Bouts, Antonia H ^b   Mathot, Ron A A ^c   Van Gelder, Teun ^d   Croes, Ludwig K ^a   Hop, Wim ^d   Cransberg, Karlien ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

adherence; immunosuppression; renal; tacrolimus; transplantation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CHILD; CORRELATION ANALYSIS; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY; KIDNEY TRANSPLANTATION; MALE; PATIENT COMPLIANCE; RENAL INSUFFICIENCY; REPRODUCIBILITY OF RESULTS; TACROLIMUS; TREATMENT OUTCOME;

EID: 84864587474     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2012.01727.x     Document Type: Article

References (21)

1. Filler G, Webb NJ, Milford DV, et al., Four-year data after pediatric renal transplantation: A randomized trial of tacrolimus vs. cyclosporin microemulsion. Pediatr Transplant 2005: 9: 498-503. (Pubitemid 41153271)
2. Neu AM, Ho PL, Fine RN, Furth SL, Fivush BA,. Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: A NAPRTCS study. Pediatr Transplant 2003: 7: 217-222. (Pubitemid 36682146)
3. Hesselink DA, Van Schaik RH, Van Der Heiden IP, et al., Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus. Clin Pharmacol Ther 2003: 74: 245-254. (Pubitemid 37083100)
4. Staatz CE, Tett SE,. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 2004: 43: 623-653. (Pubitemid 38981845)
5. Zhao W, Elie V, Roussey G, et al., Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients. Clin Pharmacol Ther 2009: 86: 609-618.
6. Naesens M, Salvatierra O, Li L, Kambham N, Concepcion W, Sarwal M,. Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients. Transplantation 2008: 85: 1139-1145. (Pubitemid 351596397)
7. Montini G, Ujka F, Varagnolo C, et al., The pharmacokinetics and immunosuppressive response of tacrolimus in paediatric renal transplant recipients. Pediatr Nephrol 2006: 21: 719-724.
8. Borra LC, Roodnat JI, Kal JA, Mathot RA, Weimar W, Van Gelder T,. High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation. Nephrol Dial Transplant 2010: 25: 2757-2763.
9. Smith JM, Ho PL, McDonald RA,. North American Pediatric Renal Transplant Cooperative Study. Renal transplant outcomes in adolescents: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2002: 6: 493-499. (Pubitemid 35470547)
10. Cecka JM, Gjertson DW, Terasaki PI,. Pediatric renal transplantation: a review of the UNOS data. United Network for Organ Sharing. Pediatr Transplant 1997: 1: 55-64. (Pubitemid 127684809)
11. Wallemacq PE, Furlan V, Möller A, et al., Pharmacokinetics of tacrolimus (FK 506) in paediatric liver transplant recipients. Eur J Drug Metab Pharmacokinet 1998: 23: 367-370. (Pubitemid 28517723)
12. Junge W, Wilke B, Halabi A, Klein G,. Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified Jaffé method. Clin Chim Acta 2004: 44: 137-148. (Pubitemid 38626148)
13. Van Rossum LK, Mathot RA, Cransberg K, Zietse R, Vulto AG,. Estimation of the glomerular filtration rate in children: Which algorithm should be used? Pediatr Nephrol 2005: 20: 1769-1775. (Pubitemid 41722963)
14. Kahan BD, Welsh M, Urbauer DL, et al., Low intraindividual variability of cyclosporin A exposure reduces chronic rejection incidence and health care costs. J Am Soc Nephrol 2000: 11: 1122-1131. (Pubitemid 30367943)
15. Pollock-Barziv SM, Finkelstein Y, Manlhiot C, et al., Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children. Pediatr Transplant 2010: 14: 968-975.
16. Nankivell BJ, Fenton-Lee CA, Kuypers DR, et al., Effect of histological damage on long-term kidney transplant outcome. Transplantation 2001: 71: 515-523. (Pubitemid 32207202)
17. Dew MA, Dabbs AD, Myaskovsky L, et al., Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation 2009: 88: 736-746.
18. Pinsky Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR,. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 2009: 11: 2597-2606.
19. Hesselink DA, Ngyuen H, Wabbijn M, et al., Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids. Br J Clin Pharmacol 2003: 3: 327-330. (Pubitemid 37059661)
20. Steiner RW, Feist AA,. The "generic" effect of food on tacrolimus pharmacokinetics. Clin Transplant 2011: 25: 334-335.
21. Webb NJ, Roberts D, Preziosi R, Keevil BG,. Fingerprick blood samples can be used to accurately measure tacrolimus levels by tandem mass spectrometry. Pediatr Transplant 2005: 9: 729-733. (Pubitemid 41680707)